Skip to content

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

Addressing Stigma in Screening and Diagnostic Delay for Cervical Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01287871
Enrollment
336
Registered
2011-02-02
Start date
2011-01-01
Completion date
2026-10-01
Last updated
2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer Screening

Keywords

Cervical Cancer Screening

Brief summary

This study aims to 1) implement a culturally and contextually rooted innovative multifoci, social marketing intervention involving societal focused media campaign elements to break down the barriers and facilitate timely and appropriate screening practices for cervical cancer; 2) measure cervical cancer stigma from a culturally relevant theoretical and conceptual framework; and 3) assess the influence of stigma on hindering seeking the PAP test. Further, this is an international study that will bring together a multi-disciplinary investigatory team, community advocates and State health agencies to deliver a social marketing intervention in Southern California (the Inland Empire region specifically) and Trinidad and Tobago.

Interventions

OTHERsupportive care

Sponsors

City of Hope Medical Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Women will be included if they: 1. have not been diagnosed with any type of cancer 2. are between the ages of 18-70 3. self-identify as being African descended or Latina 4. are able to speak English and/or Spanish 5. acknowledge that a Pap test is currently needed

Exclusion criteria

1. Cervical cancer is diagnosed only in women, therefore this study only includes women 2. Women who have been and/or are currently diagnosed with any type of cancer will be excluded 3. Women with other major medical conditions (e.g. stroke and degenerative illness) will be excluded 4. During the screening the level of symptomatology for depression and anxiety will be assessed. Women with severe depression and anxiety will be excluded, but appropriate psychological follow-up and referral will be provided 5. Women older than 70 years will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline3 months after the intervention is implementedTo evaluate the ability of the social media intervention "End Stigma End Fear, End Cervical Cancer" to counter stigma of cervical cancer, by determining whether, among disadvantaged women who acknowledge needing a Pap test at pre-intervention baseline, degree of exposure to the intervention is associated with the following endpoints at 3 months after the intervention is implemented: 1. post-intervention change in stigma score relative to pre-intervention, and 2. Pap testing (scored as 0=made no attempt, 1=made some attempt but did not get tested, 2=obtained Pap test).

Secondary

MeasureTime frame
Assessment of whether change in stigma score is associated with Pap testing.3 months after the intervention is implemented
Identification of factors associated with exposure to the intervention overall and to its individual components3 months after the intervention is implemented
Assessment of whether each component of the intervention is associated with the study endpoints, by testing the 4 components (billboards/posters, newspaper advertisements, health brochures, and radio announcements) rather than the overall exposure score3 months after the intervention is implemented

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORKimlin Ashing-Giwa, PhD

City of Hope Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026